The University of Pittsburgh School of Medicine has been an American Parkinson Disease Association Center for Advanced Research since 2005. APDA Centers for Advanced Research must meet the highest academic standards and be distinguished leaders in the field of PD research. There are eight such centers across the country.
The funding of this Center supports a large research program, which includes: Neurologists, Neuroscientists, Postdoctoral Fellows, Graduate and Undergraduate Students and Movement Disorders Fellows, as well as a Physician Assistant, Nurse and Clinical Research Coordinators. Projects range from basic laboratory bench studies to translational testing of new therapeutic strategies to clinical trials of new treatments for people with PD. The University of Pittsburgh Center has experience with both experimental and clinical gene therapy studies.
The American Parkinson Disease Association (APDA) is the largest grassroots network dedicated to fighting Parkinson’s disease (PD) and works tirelessly to assist the more than 1 million Americans with PD live life to the fullest in the face of this chronic, neurological disorder.
J. Timothy Greenamyre, MD, PhD, Love Family Professor and Director of the Pittsburgh Institute for Neurodegenerative Diseases, directs the Pitt Center.